Initial to indicate certification as to information on this page (full text of certification is on page one). Date INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary. 2. Case # and Name 3. Date and Type of DCI and Number

4. EPA Product Registration 5. I wish to cancel this product registration voluntarily 6. Generic Data 7. Product Specific Data 6a. I am claiming a Generic Data Exemption because I obtain the active ingredient from the source EPA registration number listed below. 6b. I agree to satisfy Generic Data Requirements as indicated on the attached form entitled "Requirements Status and Registrant's Response." 7a. My product is an MUP and I agree to satisfy the MUP requirement on the attached form entitled "Requirements Status and Registrant's Response." 7b. My product is an EUP and I agree to satisfy the EUP requirement on the attached form entitled "Requirements Status and Registrant's Response." OMB Approval 2070-0174

1. Company Name and Address 0040 - Chloropicrin Chemical # and Name: 081501 Chloropicrin 15-May-2012 GENERIC ID # GDCI-081501-1155 

### United States Environmental Protection Agency

Washington, D.C. 20460 DATA CALL-IN RESPONSE 1 Page of 1

8. Certification: I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that any knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law. Signature and Title of Company's Authorized Representative ______________________________________________________ 10. Name of Company N/A N/A

9. Date

11. Phone NumberDate Initial to indicate certification as to information on this page (full text of certification is on page one) 13. Phone Number 10. Certification: I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that any knowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.
12. Name of Company 11. Date OMB Approval 2070-0174 

### United States Environmental Protection Agency

Washington, D.C. 20460 REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form. Use additional sheet(s) if necessary.

4. Guideline Requirement Number 5. Study Title Progress Reports



### 2 3 1 6. Use

Pattern 7. Test Substance 8. Time Frame (Months) 9. Registrant

Response P R O T O C O L 1. Company Name and Address 2. Case # and Name 3. Date and Type of DCI and Number

Signature and Title of Company's Authorized Representative _________________________________________________________________ SS-1076 Ambient Air Monitoring 0040 - Chloropicrin Chemical # and Name: 081501 Chloropicrin 15-May-2012 GENERIC ID # GDCI-081501-1155

C EP; PAI; TGAI 36 1 of Page

(1, 2, 3, 4, 5,

6) Y 1

### United States Environmental Protection Agency Washington, D.C. 20460 FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTS 0040 - Chloropicrin GDCI-081501-1155

1
2 3 4

5
6 Key: Residue of Concern = Residue of Concern; TEP = Typical End Use Product [TEP]; TGAI = Technical Grade Active Ingredient [TGAI]; TGAI/PAIRA = Technical Grade of the Active Ingredient or Pure Active Ingredient, Radio Labelled; TGAI, TEP = Technical Grade of the Active Ingredient or Technical End-Use Product; TGAI/PAI = Technical Grade Active Ingredient, Pure Active Ingredient

The sampling design of the study must focus on community level exposures in a longitudinal fashion (i.e., repeated observations of the same variable over a period of time). Monitoring samples are to be collected at least twice per week during the chloropicrin pesticide product use season in the particular locale being monitored, and once per week during the season when chloropicrin pesticide products are not being used in the particular locale being monitored, for a period of two consecutive years. Submit a draft protocol, which includes a detailed study implementation timeline, to the Agency within 120 days of receipt of this DCI. The Agency must review and approve the protocol prior to study initiation. EPA encourages the registrants to work with existing ambient air monitoring programs such as in CA and WA or the registrants may develop their own program. Criteria that must be considered in selecting the monitoring sites include: (1) Areas of highest chloropicrin use; (2) Duration of the season of chloropicrin use for a candidate study area; (3) Geographically unique features that could affect ambient concentration levels (e.g., valleys, flat terrain); (4) Weather considerations which may adversely impact ambient exposures, e.g., frequent inversions or air stagnation events; (5) Proximity of chloropicrin use to bystander populations; (6) Proximity of chloropicrin use to sensitive populations (e.g., school children); (7) Proximity of chloropicrin use to minority populations to define potential environmental justice concerns such as disparate exposures to certain populations; and (8) Logistical access. Ambient air monitoring for chloropicrin must be conducted in at least three chloropicrin high use areas. The registrant must propose study sites in the protocol based on current chloropicrin usage data. See EPA's memo, Process for Defining High-Use Fumigation Areas at the State and County Levels, for guidance on how to determine high use areas: http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2007-0350-0405. A yearly progress report must be submitted to the Agency once the protocol has been approved, i.e. 12 months after the protocol is approved and annually thereafter. The report must: (1) Report on and demonstrate progress according to the timeline described in the approved protocol for implementation: (2) Identify and describe any protocol amendments or deviations; (3) Identify and describe any implementation issues (e.g., logistical or access issues); and (4) Report and summarize all preliminary findings to date, or in the case of subsequent annual progress reports, all preliminary findings since the last annual report. Case # and Name: DCI Number: 1 Page: of 1

Footnotes: The following footnotes are referenced in column two (5. Study Title) of the Requirements Status and Registrant's Response form. These footnotes apply in addition to any test notes included in 40 CFR Part 158 with respect to the particular data requirement. Use Categories Key: C - Terrestrial nonfood crop

### United States Environmental Protection Agency Washington, D.C. 20460 LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICE 0040 - Chloropicrin Case # and Name: 1 Page: of 1

62341 7747 5785 62531 66330 TRINITY MANUFACTURING, INC

NIKLOR CHEMICAL CO., INC. GREAT LAKES CHEMICAL CORPORATION ASHTA CHEMICALS, INC. ARYSTA LIFESCIENCE NORTH AMERICA, LLC Co. Nr. Company Name Agent For Company EDWARD W. LYLE

CHEMTURA CORPORATION 1805 45TH ST., N.W. 1667 PURDY AVE. 1801 HIGHWAY 52 WEST 3509 MIDDLE ROAD, P.O. Box 858 15401 WESTON PARKWAY, SUITE 150 Address City ZIP WASHINGTON MOJAVE WEST LAFAYETTE ASHTABULA CARY 200072070 93501 47906 440050858 27513 OMB Approval 2070-0174

State DC CA IN OH NC DCI Number: GDCI-081501-1155

# LINKS TO FORMS: The pesticide registration forms that are listed below can be found at: http://www.epa.gov/opprd001/forms/ Link to C onfidential Statement of Formula and Instructions (Form # 8570 -4 

# ) http://www.epa.gov/opprd001/forms/8570 - 4.pdf C ertification of Attempt to Enter Into an Agreement With Registrants for Development of Data (Form # 8570 - 32 

# ) http://www.epa.gov/opprd001/forms/8570 - 32.pdf C ertification With Respect to Citation of Data (Form # 8570 - 34 

# ) http://www.epa.gov/opprd001/forms/8570 - 34.pdf